Mind over migraine: study tests if ACT therapy eases daily disability
NCT ID NCT06795867
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether Acceptance and Commitment Therapy (ACT), a type of behavioral training, can improve daily functioning in adults with chronic migraine. Forty participants will either receive ACT plus their usual care or just usual care alone. Over a year, they will fill out questionnaires and headache diaries to see if ACT helps reduce disability and improve quality of life.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Acceptance and Commitment Therapy (ACT) - a behavioral therapy that teaches psychological flexibility
What this could lead to
If it works, this could offer a new non-drug option to help people with chronic migraine feel more functional and less disabled by their condition.
What could go wrong
This is a small, early-stage trial with only 40 people, so results may not apply to everyone. ACT requires time and effort, and may not reduce headache frequency or pain for all participants.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC MIGRAINE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Brigham and Women's / Faulkner Hospital
RECRUITINGBoston, Massachusetts, 02130, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••